Literature DB >> 17437956

Lung cancer mortality at a UK tin smelter.

S R Jones1, P Atkin, C Holroyd, E Lutman, J Vives I Batlle, R Wakeford, P Walker.   

Abstract

BACKGROUND: An earlier study of mortality among male former employees at a tin smelter in Humberside, UK, had identified excess mortality from lung cancer, which appeared to be associated with occupational exposure. AIMS: The aim of the present study was to investigate the relationship between lung cancer mortality and quantitative measures of exposure.
METHODS: Using available records of occupational hygiene measurements, we established exposure matrices for arsenic, cadmium, lead, antimony and polonium-210 ((210)Po), covering the main process areas of the smelter. We established work histories from personnel record cards for the previously defined cohort of 1462 male employees. Three different methods of extrapolation were used to assess exposures prior to 1972, when no measurement results were available. Lung cancer mortality was examined in relation to cumulative inhalation exposure by Poisson regression analysis.
RESULTS: No significant associations could be found between lung cancer mortality and simple cumulative exposure to any of the substances studied. When cumulative exposures were weighted according to time since exposure and attained age, significant associations were found between lung cancer mortality and exposures to arsenic, lead and antimony.
CONCLUSIONS: The excess of lung cancer mortality in the cohort can most plausibly be explained if arsenic is the principal occupational carcinogen (for which the excess relative risk diminishes with time since exposure and attained age) and if there is a contribution to excess mortality from an enhanced prevalence of smoking within the cohort. The implications of the dose-response for arsenic exposure for risk estimation merit further consideration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17437956     DOI: 10.1093/occmed/kql153

Source DB:  PubMed          Journal:  Occup Med (Lond)        ISSN: 0962-7480            Impact factor:   1.611


  7 in total

1.  Cadmium and lung cancer mortality accounting for simultaneous arsenic exposure.

Authors:  Robert M Park; Leslie T Stayner; Martin R Petersen; Melissa Finley-Couch; Richard Hornung; Carol Rice
Journal:  Occup Environ Med       Date:  2012-01-22       Impact factor: 4.402

Review 2.  Cadmium exposure and risk of lung cancer: a meta-analysis of cohort and case-control studies among general and occupational populations.

Authors:  Cheng Chen; Pengcheng Xun; Muneko Nishijo; Ka He
Journal:  J Expo Sci Environ Epidemiol       Date:  2016-03-09       Impact factor: 5.563

3.  The exposure to and health effects of antimony.

Authors:  Ross G Cooper; Adrian P Harrison
Journal:  Indian J Occup Environ Med       Date:  2009-04

4.  The Comparative Toxicogenomics Database facilitates identification and understanding of chemical-gene-disease associations: arsenic as a case study.

Authors:  Allan P Davis; Cynthia G Murphy; Michael C Rosenstein; Thomas C Wiegers; Carolyn J Mattingly
Journal:  BMC Med Genomics       Date:  2008-10-09       Impact factor: 3.063

5.  The dose-response association of urinary metals with altered pulmonary function and risks of restrictive and obstructive lung diseases: a population-based study in China.

Authors:  Wei Feng; Xiji Huang; Ce Zhang; Chuanyao Liu; Xiuqing Cui; Yun Zhou; Huizhen Sun; Gaokun Qiu; Huan Guo; Meian He; Xiaomin Zhang; Jing Yuan; Weihong Chen; Tangchun Wu
Journal:  BMJ Open       Date:  2015-05-21       Impact factor: 2.692

6.  Risk of Cancer for Workers Exposed to Antimony Compounds: A Systematic Review.

Authors:  Anton Saerens; Manosij Ghosh; Jelle Verdonck; Lode Godderis
Journal:  Int J Environ Res Public Health       Date:  2019-11-14       Impact factor: 3.390

7.  Occupational exposure to antimony trioxide: a risk assessment.

Authors:  Samantha Schildroth; Gwendolyn Osborne; Anna R Smith; Caryn Yip; Caroline Collins; Martyn T Smith; Martha S Sandy; Luoping Zhang
Journal:  Occup Environ Med       Date:  2020-11-26       Impact factor: 4.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.